• Chiari I Malformation
• Cervical Spinal Stenosis
• Low Blood Pressure
• MRI Requirements
• Patient Testimonials
• Neurological-Connection-to-FM
• Calendar of Events
• NFRA Symposiums
• Awareness Bracelet
• Awareness Pin
• Resources & Web Links
• Home
• Fibromyalgia Sleep

• Cervical Spinal Stenosis Abstract I
• Cervical Spinal Stenosis II
• Cervical Spinal Stenosis III

• Low Blood Pressure Abstract I
• Low Blood Pressure Abstract II
• Low Blood Pressure Abstract III
• Low Blood Pressure Abstract IV

• MRI Requirements
• MRI Requirements

• Testimonials Lauri1
• Testimionials Tamara1
• Testimonials Helen1
• Testimonials Sharon1

Chiari I Malformation

• Chiari 1
• Chiari 2
• Chairi 3
• Chiari 4
• Chiari 5
• Chiari 6
• Chiari 7

Low Blood Pressure

• Low Blood Pressure Abstract 1
• Low Blood Pressure Abstract II
• Low Blood Pressure Abstract III
• Low Blood Pressure Abstract IV

Science

• A deficit of endogenous
• Abnormal functional activity
• abnormal pain processing in FM
• Abnormalities of regional cerebral blood flow
• accelerated gray brain matter loss
• Antipolymer antibody reactivity
• Autonomic dysfunction
• Bigatti Sleep
• Body pain area and pain-related negative affect
• Central Dopamine
• cerebrospinal fluid corticotrophin-releasing factor
• cerebrospinal fluid that correlate
• Cervical myelopathy and fibromyalgia
• Cervical myelopathy due to Chiari malformation
• Chaos Theory
• Chiari I malformation redefined
• Chiari malformation and FM Syndrome
• chronic inflammatory demyelinating polyneuropathy
• Controlling pathological pain
• Decreased central mu-opioid receptor availability
• Development of milnaciprin
• dopaminergic control of sleep-wake states
• Duloxetine 6 month
• Effects of sodium oxybate
• efficacy of milnacipran in patients with fibromyalgia
• Endogenous pain inhibitory systems
• Fibromyalgia abstracts table of contents
• fibromyalgia as a sympathetically
• Fibromyalgia Glossary
• Fibromyalgia know the source
• FREEDOM
• Functional abnormalities of the cervical cord
• Functional and symptomatic outcome
• functional magnetic resonance imaging
• Gabapentin in the treatment of fibromyalgia
• Genetic linkage analysis
• growth hormone perturbation in fibromyalgia
• growth hormone secretion
• Hippocampus Dysfunction
• Immune regulation of central nervous system
• Immune-to-brain communication
• Impact of quality of life with tramadol
• Implications of hypothalamic-pituitary-adrenal axis dysregulation
• involvement of central neural mechanisms
• Is cervical myelopathy overlooked
• is fibromyalgia a generalized
• joint hypermobility and fibromyalgia
• Long term outcome
• Mesolimbic dopaminergic mechanisms
• Might glia be the culprit
• Milnacipran_clauw
• Milnacipran_mease
• Moldofsky_2008
• musculoskeletal findings in obese subjects
• Naschitz_2008
• natelson_cytokine
• nerve growth factor
• neurally mediated hypotension
• Neurobiology of fibromyalgia syndrome
• Neuroendocrine abnormalities
• Neurosurgical subset of fibromyalgia
• Neurotransmitter Imbalances
• NFRA Funded Research